Georgia is currently facing a severe flu outbreak as patients afflicted with the said disease rush to hospitals in one of its counties. Tifton Gazette reports that as of Feb. 18, there are already 490 confirmed cases at the Tift Regional Medical Center (TRMC). Other than the staggering number of cases, there are over 1,100 people showing up with influenza-like symptoms.
At around the same time last year, Tift County only had around 150 flu cases. Now that the number has more than tripled, citizens are alarmed, and hospitals have become busy. The Tift Regional Health System, which measured the number of cases, hasn’t included in the count the cases from doctor’s offices and clinics in the county.
TRMC director of infection prevention Mary Key notes that the flu season reached its peak earlier than usual, which is at the third week of January. She adds that the flu activity typically climbs to its highest in March, with February being the earliest. For now, Key says that the heightened flu activity could die out this March but that Georgians shouldn’t let their guard down just yet as it is not a “100 percent guarantee.”
Doctors are advising the citizens to wash their hands frequently to avoid coming into contact with the disease. To stop the flu epidemic from spreading even further, they also suggest that people cough or sneeze into their sleeves if necessary, as it prevents the virus from going airborne. Key is also advising people to take a flu vaccine, which she says is still effective even if the flu season has already arrived.
Those who are most vulnerable to the flu are the children, the elderly, pregnant women, and people with chronic conditions.
Georgia and Tift County are having a tough time with the flu epidemic now, but soon enough, the state and the other parts of the world could be battling flu with ease once Japanese pharmaceutical company Shionogi & Co. starts distributing its drug that can rid people of the influenza virus in a day.
Xofluza now approved in Japan
What could be a groundbreaking drug that kills the virus has now been approved by the Japanese health ministry, says a report by The Wall Street Journal.
With the approval, Shionogi & Co. can finally begin distributing the Xofluza drug, which is said to eradicate the virus within 24 hours. As compared to other flu medicines like Tamiflu, Xofluza requires only a single dosage. Tamiflu, on the other hand, is administered to the patient in a span of five days.
There is no exact date on when Xofluza will be available in the U.S., but Shionogi & Co. already has plans to get the drug approved in the said country. For now, the company notes that getting an approval before 2019 is unlikely.
Xofluza could revolutionize the way doctors and patients fight the influenza virus. Hopefully, countries like the U.S. will have access to the medicine soon. Just last year, the flu costs the said country a whopping $10.4 billion, says CNBC. The cost accounts for lost labor, hospital bills and more. Through Xofluza, the cost could decrease dramatically.
Crowdfunding campaign for a mulcher exceeds its target
The association Bürgerparkgesellschaft von 1875 Sulingen recently closed a very successful crowdfunding campaign with the target of $4,400 (€3,800). The...
E-Euro: Finland also promotes cryptocurrencies
Finland is one of the first euro countries, since 2002 the euro has replaced the Finnish mark in everyday life....
Why countries in southern Africa could become leaders in the cannabis sector
Africa’s south wants to become the world market leader in cannabis production. The conditions for this are favorable. John Kagia...
How to market your business during and after the pandemic
After the pandemic outburst, the online content seen on digital media evolved as brands started to acknowledge the situation. It...
Hot junior miner Rockridge Resources goes all-in at the Raney Gold Project
Junior Miner Rockridge Resources has just announced that they’ve earned a 100% stake in the promising Raney Gold Project. Now...
Featured7 days ago
Qonto registered over €900 million value of transactions on Italian current accounts
Business7 days ago
Three reasons B2B companies should invest in brand marketing
Featured5 days ago
Which fintech company raised the most funds in Q3 2020?
Biotech7 days ago
2020, a record year for regenerative medicine and advanced therapies